跳至主要内容
临床试验/TCTR20200821005
TCTR20200821005已完成3 期

Efficacy of Split-Dose versus Single Dose of Ergocalciferol on Serum 25(OH)D in CAPD Patient: A Randomized Controlled Trial

one0 个研究点目标入组 50 人开始时间: 2020年8月21日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
one
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • inclusion criteria were CAPD patient with dialysis before enrolled for at least three months, aged > 18 years, who were diagnosed vitamin D deficiency and insufficiency, defined by vitamin D insufficiency was of 20â€29 ng/mL and deficiency was less than 20 ng/mL.

排除标准

  • Subjects with history of liver diseases, patients known to have hypocalcaemia, hypercalcaemia or hyperparathyroidism, pregnant and lactating women, and history of urinary tract stone were excluded from the study. Discontinuation criteria included unwillingness to continue study, intolerable side-effects or allergy.

研究者

发起方
one

相似试验